-
The U.S. Preventive Services Task Force (USPSTF) periodically releases some updates on guidelines, always concluding with a recommendation.
MedNews (Diabetology) - Fri, 14 November 2008
http://mn.medsurfnews.com/
-
Even if a relation between depression onset and diabetes has been observed many times, the time relation linking these two conditions has never been cleared up.
MedNews (Diabetology) - Fri, 14 November 2008
http://mn.medsurfnews.com/
-
Objective of the study is to examine the efficacy of low-dose aspirin for the primary prevention of atherosclerotic events in patients with type 2 diabetes.
Journal of the American Medical Association (Diabetology) - Thu, 13 November 2008
http://jama.ama-assn.org/
-
A randomized trial shows that vitamin K supplementation for 36 months at doses attainable in the diet may reduce progression of insulin resistance in older men.
Medscape (Diabetology) - Thu, 30 October 2008
http://www.medscape.com
-
We know that in the short term a change in lifestyle (increase in physical exercise and diet control) in subjects presenting an impaired glucose tolerance can delay the onset of diabetes mellitus.
MedNews (Diabetology) - Wed, 22 October 2008
http://mn.medsurfnews.com/
-
A new study shows no evidence that aspirin or antioxidants are of any benefit in the primary prevention of cardiovascular events in diabetic patients with asymptomatic peripheral arterial disease.
Medscape (Diabetology) - Wed, 22 October 2008
http://www.medscape.com
-
There is no clear evidence that an intensive glycemic control of type 2 diabetes is capable to decrease the incidence of macro-vascular complications, so two new trials have been performed on this particular aspect.
MedNews (Diabetology) - Mon, 13 October 2008
http://mn.medsurfnews.com/
-
It is known that the Mediterranean diet (a great amount of vegetables, olive oil, moderate intake of alcohol) decreases cardiovascular risk, but there is no clear evidence yet on its capability to decrease the risk of type 2 diabetes mellitus.
MedNews (Diabetology) - Mon, 13 October 2008
http://mn.medsurfnews.com/
-
We know that the main cause of type 2 diabetes progression is in the pancreatic cellular damage provoked by a constant hyperglycemia. It was also seen that the use of an intensive insulin therapy in a newly diagnosed diabetes implied the keeping of a glycemic compensation for long terms, without using further drugs.
MedNews (Diabetology) - Mon, 13 October 2008
http://mn.medsurfnews.com/
-
Aliskiren – a direct inhibitor of rennin – was approved by FDA in 2007 for the treatment of hypertension, and now this trial, sponsored by pharmaceutical industry, was performed to verify whether a double block of the rennin-angiotensin-aldosterone system (reached with aliskiren plus a sartan) can decrease proteinuria in nephropathic diabetic patients.
MedNews (Diabetology) - Thu, 2 October 2008
http://mn.medsurfnews.com/